Abstract
Background
Increased, decreased, as well as unchanged pituitary volumes have been reported in bipolar disorders (BD). It is unclear, whether abnormal pituitary volumes increase vulnerability for BD (primary vulnerability marker), or are secondary to burden of illness. To address this question, we performed the first high-risk study of pituitary volumes in affected and unaffected relatives of bipolar subjects.
Method
High-risk participants (age range 15–30 years) were recruited from families multiply affected with BD and included 24 unaffected, 19 affected subjects with first or second degree bipolar I or II relative, matched by age and sex with 31 controls without a personal or family history of psychiatric disorders. Pituitary volumes were measured on 1.5 T 3D anatomical MRI images using standard methods.
Results
We found comparable pituitary volumes among unaffected, affected relatives of bipolar patients and controls. There were no differences in pituitary volumes between male and female subjects nor was there any sex by group interaction. Analyzing 26 participants with bipolar I parent or excluding 5 medicated subjects did not change the results. There were no differences between subjects from families containing bipolar I versus families containing only bipolar II subjects.
Conclusions
The lack of abnormalities in unaffected and also affected subjects early in the course of illness in our study, as well as previous investigations of bipolar and familial unipolar children and adolescents, suggest that pituitary volume abnormalities are unlikely to be a primary risk factor for mood disorders.
Similar content being viewed by others
References
Axelson DA, Doraiswamy PM, Boyko OB, Rodrigo EP, McDonald WM, Ritchie JC et al (1992) In vivo assessment of pituitary volume with magnetic resonance imaging and systematic stereology: relationship to dexamethasone suppression test results in patients. Psychiatry Res 44:63–70
Beresford T, Arciniegas D, Rojas D, Sheeder J, Teale P, Aasal R et al (1999) Hippocampal to pituitary volume ratio: a specific measure of reciprocal neuroendocrine alterations in alcohol dependence. J Stud Alcohol 60:586–588
Bielau H, Trubner K, Krell D, Agelink MW, Bernstein HG, Stauch R et al (2005) Volume deficits of subcortical nuclei in mood disorders: a postmortem study. Eur Arch Psychiatry Clin Neurosci 255:401–412
Chen HH, Nicoletti M, Sanches M, Hatch JP, Sassi RB, Axelson D et al (2004) Normal pituitary volumes in children and adolescents with bipolar disorder: a magnetic resonance imaging study. Depress Anxiety 20:182–186
Cox RW (1996) AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res 29:162–173
Czeh B, Lucassen PJ (2007) What causes the hippocampal volume decrease in depression? Are neurogenesis, glial changes and apoptosis implicated? Eur Arch Psychiatry Clin Neurosci 257:250–260
Duffy A, Alda M, Kutcher S, Cavazzoni P, Robertson C, Grof E et al (2002) A prospective study of the offspring of bipolar parents responsive and nonresponsive to lithium treatment. J Clin Psychiatry 63:1171–1178
Endicott J, Spitzer RL (1978) A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry 35:837–844
Garner B, Pariante CM, Wood SJ, Velakoulis D, Phillips L, Soulsby B et al (2005) Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis. Biol Psychiatry 58:417–423
Gershon ES, Hamovit J, Guroff JJ, Dibble E, Leckman JF, Sceery W et al (1982) A family study of schizoaffective, bipolar I, bipolar II, unipolar, and normal control probands. Arch Gen Psychiatry 39:1157–1167
Gispert JD, Reig S, Pascau J, Vaquero JJ, Garcia-Barreno P, Desco M (2004) Method for bias field correction of brain T1-weighted magnetic resonance images minimizing segmentation error. Hum Brain Mapp 22:133–144
Hajek T, Carrey N, Alda M (2005) Neuroanatomical abnormalities as risk factors for bipolar disorder. Bipolar Disord 7:393–403
Hajek T, Gunde E, Bernier D, Slaney C, Propper L, Grof P et al (2007) Subgenual cingulate volumes in affected and unaffected offspring of bipolar parents. J Affect Disord (in press)
Hoschl C, Hajek T (2001) Hippocampal damage mediated by corticosteroids–a neuropsychiatric research challenge. Eur Arch Psychiatry Clin Neurosci 251(Suppl 2):II81–II88
Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P et al (1997) Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36:980–988
Krishnan KR, Doraiswamy PM, Lurie SN, Figiel GS, Husain MM, Boyko OB et al (1991) Pituitary size in depression. J Clin Endocrinol Metab 72:256–259
Maas DL, Hunt S, Mark L, Drobny EC (1996) Reversible thioridazine-induced magnetic resonance imaging-documented pituitary enlargement associated with hyperprolactinemia. Endocr Pract 2:85–89
MacMaster FP, El Sheikh R, Upadhyaya AR, Nutche J, Rosenberg DR, Keshavan M (2007) Effect of antipsychotics on pituitary gland volume in treatment-naive first-episode schizophrenia: a pilot study. Schizophr Res 92:207–210
MacMaster FP, Kusumakar V (2004) MRI study of the pituitary gland in adolescent depression. J Psychiatr Res 38:231–236
MacMaster FP, Russell A, Mirza Y, Keshavan MS, Taormina SP, Bhandari R et al (2006) Pituitary volume in treatment-naive pediatric major depressive disorder. Biol Psychiatry 60:862–866
McDonald C, Marshall N, Sham PC, Bullmore ET, Schulze K, Chapple B et al (2006) Regional brain morphometry in patients with schizophrenia or bipolar disorder and their unaffected relatives. Am J Psychiatry 163:478–487
Oren DA, Levendosky AA, Kasper S, Duncan CC, Rosenthal NE (1996) Circadian profiles of cortisol, prolactin, and thyrotropin in seasonal affective disorder. Biol Psychiatry 39:157–170
Pariante CM, Dazzan P, Danese A, Morgan KD, Brudaglio F, Morgan C et al (2005) Increased pituitary volume in antipsychotic-free and antipsychotic-treated patients of the AEsop first-onset psychosis study. Neuropsychopharmacology 30:1923–1931
Pariante CM, Vassilopoulou K, Velakoulis D, Phillips L, Soulsby B, Wood SJ et al (2004) Pituitary volume in psychosis. Br J Psychiatry 185:5–10
Phillips ML, Drevets WC, Rauch SL, Lane R (2003) Neurobiology of emotion perception II: implications for major psychiatric disorders. Biol Psychiatry 54:515–528
Rubin RT, Phillips JJ, Sadow TF, McCracken JT (1995) Adrenal gland volume in major depression. Increase during the depressive episode and decrease with successful treatment. Arch Gen Psychiatry 52:213–218
Sassi RB, Nicoletti M, Brambilla P, Harenski K, Mallinger AG, Frank E et al (2001) Decreased pituitary volume in patients with bipolar disorder. Biol Psychiatry 50:271–280
Schwartz PJ, Loe JA, Bash CN, Bove K, Turner EH, Frank JA et al (1997) Seasonality and pituitary volume. Psychiatry Res 74:151–157
Starkman MN, Giordani B, Gebarski SS, Berent S, Schork MA, Schteingart DE (1999) Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing’s disease. Biol Psychiatry 46:1595–1602
Todd RD, Reich W, Petti TA, Joshi P, DePaulo JR Jr, Nurnberger J Jr et al (1996) Psychiatric diagnoses in the child and adolescent members of extended families identified through adult bipolar affective disorder probands. J Am Acad Child Adolesc Psychiatry 35:664–671
Weber-Hamann B, Hentschel F, Kniest A, Deuschle M, Colla M, Lederbogen F et al (2002) Hypercortisolemic depression is associated with increased intra-abdominal fat. Psychosom Med 64:274–277
Acknowledgments
Supported by NARSAD Young Investigator Award to Dr. Hajek and grants from the Department of Psychiatry, Dalhousie University, Capital District Health Authority. None of the authors has any conflict of interest to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hajek, T., Gunde, E., Bernier, D. et al. Pituitary volumes in relatives of bipolar patients. Eur Arch Psychiatry Clin Neurosc 258, 357–362 (2008). https://doi.org/10.1007/s00406-008-0804-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00406-008-0804-0